Today RANZCO participated in the Choosing Wisely Australia launch, together with 13 other Colleges and professional associations.
The launch took place at the offices of NPS Medicinewise in Sydney, and included representatives of Colleges and professional associations, together with consumer groups, government representatives, journalists, and other stakeholders.
Altogether, 61 new Choosing Wisely messages were launched today, five of which by RANZCO:
In the absence of relevant history, symptoms and signs, ‘routine’ automated visual fields and optical coherence tomography are not indicated.
AREDS-based vitamin supplements only have a proven benefit for patients with certain subtypes of age-related macular degeneration. There is no evidence to prescribe these supplements for other retinal conditions, or for patients with no retinal disease.
Don’t prescribe tamsulosin or other alpha-1 adrenergic blockers without first asking the patient about a history of cataract or impending cataract surgery.
Intravitreal injections may be safely performed on an outpatient basis. Don’t perform routine intravitreal injections in a hospital or day surgery setting unless there is a valid clinical indication.
In general there is no indication to perform prophylactic retinal laser or cryotherapy to asymptomatic conditions such as lattice degeneration (with or without atrophic holes), for which there is no proven benefit.
The launch was attended by Dr Clayton Barnes, Chair of RANZCO’s Choosing Wisely Committee, and A/Prof Alex P Hunyor, Chair of RANZCO’s Medicare Advisory Committee.
After the launch, Dr Barnes addressed RANZCO’s staff members at the RANZCO office in Sydney, explaining the campaign messages and their development process.
For more information, please see: